Consistent with the synergic regulation of Hh and Wnt pathways, the crosstalk protein SFRP1 carrying a GLI-binding site [68,69] resulted as decreased by SMO antagonists in NBCCS-HF, CAFs and healthy fibroblasts (Table 3). The gene discussed is GLI1; the disease is hydrops fetalis.